DARATUMUMAB

UNII: 4Z63YK6E0E
Preferred Substance Name: DARATUMUMAB

945721-28-8
3003-005
DARATUMUMAB [INN]
DARATUMUMAB [JAN]
DARATUMUMAB [MI]
DARATUMUMAB [PURPLE BOOK CDER]
DARATUMUMAB [USAN]
DARATUMUMAB [WHO-DD]
DARATUMUMAB-FIHJ
DARZALEX
DARZALEX FASPRO COMPONENT DARATUMUMAB
HUMAXCD38
HUMAX-CD38
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD38 (ANTIGEN)) (HUMAN MONOCLONAL 3003-005 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3003-005 .KAPPA.-CHAIN, DIMER

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

DARATUMUMAB

Synonyms and Mappings

Resources

Note